Form 4 for INAB IN8BIO, INC.

Accepted 2021-08-03 00:00:00 ET · period of report 2021-08-03 · accession 0001209191-21-049376 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2021-08-03	2021-08-03	INAB	Ho William Tai-Wei	Pres, CEO, CFO, Dir	C - Cnv Deriv	—	+3,070	73.0K	+4%	—
DI	2021-08-03	2021-08-03	INAB	Ho William Tai-Wei	Pres, CEO, CFO, Dir	C - Cnv Deriv	$0.00	-2,792	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-08-03	C	A	3,070	—	72,999	I By child	—	—	(F1) Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering.
2	Derivative	Series A Preferred Stock	2021-08-03	C	D	2,792	$0.00	0	I By child	— · — to —	3,070 Common Stock	(F1) Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering.